Skip to main content
. 2011 Nov 8;286(52):44350–44356. doi: 10.1074/jbc.M111.282442

TABLE 2.

CV, LOD, and LOQ (all steps of the analysis included) of plasma samples

CV
LOD LOQ
Controlsa HD patientsb
% pmol/ml
N6-acetyl lysine 1–10 6–14 2.1 6.2
N6-formyl lysine 1–7 8–24 4.1 12.3
N6-lactoyl lysine 1–13 6–16 1.7 5.1
N6-glycerinyl lysine 1–20 10–18 1.3 4.0
CML 1–13 8–26 5.6 16.9
CEL 1–12 7–20 5.0 14.9

a 11 subjects, replicate analyses (n = 2).

b 18 subjects, replicate analyses (n = 6).